Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Grønlund Holm

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Psoriasis (Auckland, N.Z.)|January 31, 2019
Type 2 diabetes and psoriasis: links and risksJesper Grønlund Holm, Simon Francis Thomsen
The Journal of Dermatological Treatment|May 18, 2017
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidenceJesper Grønlund Holm, Ilya Ivyanskiy, Simon Francis Thomsen
Dermatologic Therapy|July 13, 2020
Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literatureMisbah Noshela Ghazanfar, Jesper Grønlund Holm, Simon Francis Thomsen
Dermatologic Therapy|January 10, 2020
Dupilumab for prurigo nodularis: Case series and review of the literatureJesper Grønlund Holm, Tove Agner, Carsten Sand, et al.
International Journal of Dermatology|June 24, 2016
Omalizumab for atopic dermatitis: case series and a systematic review of the literatureJesper Grønlund Holm, Tove Agner, Carsten Sand, et al.
Clinical Case Reports|December 28, 2020
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safetyAstrid-Helene Ravn Jørgensen, Jesper Grønlund Holm, Simon Francis Thomsen
Archives of Dermatological Research|February 17, 2019
Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic marchJesper Grønlund Holm, Tove Agner, Maja-Lisa Clausen, et al.
Dermatology (Basel, Switzerland)|February 14, 2019
Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University DepartmentJesper Grønlund Holm, Maja-Lisa Clausen, Tove Agner, et al.
Archives of Dermatological Research|December 19, 2019
Factors affecting quality of life in patients with hidradenitis suppurativaAstrid-Helene Ravn Jørgensen, Jesper Grønlund Holm, Misbah Noshela Ghazanfar, et al.
Dermatology (Basel, Switzerland)|March 17, 2021
Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic DermatitisJesper Grønlund Holm, Guillem Hurault, Tove Agner, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Psoriasis (Auckland, N.Z.)|January 31, 2019
Type 2 diabetes and psoriasis: links and risksJesper Grønlund Holm, Simon Francis Thomsen
The Journal of Dermatological Treatment|May 18, 2017
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidenceJesper Grønlund Holm, Ilya Ivyanskiy, Simon Francis Thomsen
Dermatologic Therapy|July 13, 2020
Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literatureMisbah Noshela Ghazanfar, Jesper Grønlund Holm, Simon Francis Thomsen
Dermatologic Therapy|January 10, 2020
Dupilumab for prurigo nodularis: Case series and review of the literatureJesper Grønlund Holm, Tove Agner, Carsten Sand, et al.
International Journal of Dermatology|June 24, 2016
Omalizumab for atopic dermatitis: case series and a systematic review of the literatureJesper Grønlund Holm, Tove Agner, Carsten Sand, et al.
Clinical Case Reports|December 28, 2020
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safetyAstrid-Helene Ravn Jørgensen, Jesper Grønlund Holm, Simon Francis Thomsen
Archives of Dermatological Research|February 17, 2019
Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic marchJesper Grønlund Holm, Tove Agner, Maja-Lisa Clausen, et al.
Dermatology (Basel, Switzerland)|February 14, 2019
Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University DepartmentJesper Grønlund Holm, Maja-Lisa Clausen, Tove Agner, et al.
Archives of Dermatological Research|December 19, 2019
Factors affecting quality of life in patients with hidradenitis suppurativaAstrid-Helene Ravn Jørgensen, Jesper Grønlund Holm, Misbah Noshela Ghazanfar, et al.
Dermatology (Basel, Switzerland)|March 17, 2021
Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic DermatitisJesper Grønlund Holm, Guillem Hurault, Tove Agner, et al.
Pageof 2